Published in Medicine and Law Weekly, March 17th, 2006
The patent covers a series of sedative compounds, including CNS 7056X, which is in preclinical development. The EPO is the first to grant the patent. National applications are pending in other key territories including the USA and Japan. The patent application, (No 00930686.1, publication number 1183243) was assigned to CeNeS from GlaxoSmithKline in November 2003.
CeNeS' short-acting sedatives are being developed for use in patients undergoing short diagnostic and surgical procedures. CNS 7056X is CeNeS' lead...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.